Global edition
Region
NewsCase StudiesWebcastsInterviewsEventsPodcastsMagazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Leadership
  • AI in Pharma
  • Manufacturing
  • Marketing
  • HR in Pharma
  • Microbiology & CCS
  • Regulatory Landscape
Formats
  • News & Analysis
  • Interviews
  • Case Studies
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
  • Partner with us
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Home/Webcasts/Regulatory Compliance
On demandRegulatory Compliance

Annex 1 Contamination Control Strategy — 18 Months In

What we have learnt from the first wave of Annex 1 inspections: what a good CCS looks like on paper, what inspectors challenge in person, and how to close the gap.

Host & moderator
Dr. Anika Desai
Head of Quality Assurance · Novartis
Date
Wed 1 Jul 2026
Time
11:00 UTC
Duration
45 min
Price
Free
Registration
--
Days
--
Hrs
--
Min
--
Sec

Registration opens soon

This session isn't open for sign-up yet. Browse the schedule or join the alerts list and we'll send an invite the moment it goes live.

Browse webcasts
About this session

Eighteen months into the revised EU GMP Annex 1, a clearer picture has emerged of how inspectors interpret the contamination control strategy expectation. This on-demand session reviews the observation patterns from a set of anonymised inspections and translates them into a concrete CCS structure that stands up to challenge.

The session covers isolator vs RABS decision-making, environmental monitoring programme redesign, and how to demonstrate — not merely document — a controlled state.

Session agenda

11:00 – 11:10
The inspection landscape

Where inspectors are focusing, and how the CCS expectation has evolved since the guideline took effect.

11:10 – 11:30
Anatomy of a defensible CCS

Structure, risk linkage, and the evidence chain that connects controls to monitoring outcomes.

11:30 – 11:45
Common gaps and quick wins

The three CCS gaps we see most often, and the fastest paths to closure.

What you'll take away

1
Observation patterns from the first 18 months of Annex 1 inspections
2
A CCS structure that maps cleanly to inspector expectations
3
How to justify isolator vs RABS choices in your CCS narrative
4
Redesigning EM programmes so results demonstrate control, not merely presence

Your speakers

Host
Dr. Anika Desai
Head of Quality Assurance · Novartis
Panelist
Sofia Martel
Senior Pharmacovigilance Scientist · Sanofi

Good to know

Is a CCS mandatory for non-sterile sites?+

The Annex 1 CCS requirement applies to sterile manufacturing; the principles remain useful for non-sterile sites but are not enforced under Annex 1.

Do you provide a CCS template?+

Yes — attendees can download a starter CCS structure that mirrors the framework demonstrated in the session.

How often should the CCS be reviewed?+

At minimum annually and after any significant process, facility, or equipment change — this is covered in the closing section.

Session details
DateWed 1 Jul 2026
Time11:00 UTC
Duration45 minutes
FormatOn demand
LanguageEnglish
CostFree
Register free
Who should attend
Sterile manufacturing site leadershipMicrobiology and QC leadsQuality Assurance and GMP compliance teamsEngineering and facilities professionals supporting Grade A/B areas
Presented with
Pharma Now

This session is produced independently by the Pharma Now editorial team.

Watch on demand

All webcasts →
Decentralised Clinical Trials — Meeting ICH E6(R3) Expectations
60 min
Regulatory Compliance

Decentralised Clinical Trials — Meeting ICH E6(R3) Expectations

Wed 19 Aug 2026
Pharmacovigilance Signal Detection with Real-World Evidence
75 min
Regulatory Compliance

Pharmacovigilance Signal Detection with Real-World Evidence

Wed 5 Aug 2026
GxP Data Integrity in Cloud-Based Quality Systems
60 min
Regulatory Compliance

GxP Data Integrity in Cloud-Based Quality Systems

Wed 22 Jul 2026
Never miss a session

Get a calendar invite the moment a webcast is announced.

One short email per session — title, speakers, and a one-click add to your calendar. Nothing else.